the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences

Pharmaceutical Market Research

<< Previous Page:   4   5   6   7   8   9   10   11   12   13   14   15   Next >>

Reports

Chinese Markets for Pain and Fever Relief Drugs
Table of Contents Published: 2009/06 Published by: Asia Market Information & Development Co.
This new study examines China' s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-te ...

Chinese Markets for Pharmaceutical Packaging
Table of Contents Published: 2009/06 Published by: Asia Market Information & Development Co.
China' s demand for Pharmaceutical Packaging has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry developm ...

Commercial Insight: Asthma & COPD - On the verge of generic entry
Table of Contents Published: 2009/06 Published by: Datamonitor
Although the respiratory market has expanded considerably from 2004 to 2008, growth in the seven major markets is slowing down from 2009 to 2011, after which sales will decline due to patent expiries of leading brands. Growth is driven by the expansion of ...

Commercial Insight: Cytotoxic Therapies - Market growth will slow due to increasing genericization
Table of Contents Published: 2009/06 Published by: Datamonitor
The cytotoxics market is mature and characterized by an increasing level of genericization. Several blockbuster products will undergo patent expiry during the forecast period, however, by virtue of these drugs' success, generic entry will ensure continued ...

Cough, Cold and Allergy (Hay Fever) Remedies in Argentina
Table of Contents Published: 2009/06 Published by: Euromonitor International
Euromonitor International' s Cough, Cold and Allergy Products in Argentina report offers a comprehensive guide to the size and shape of the market at a national level. ...

Cough, Cold and Allergy (hay Fever) Remedies in Egypt
Table of Contents Published: 2009/06 Published by: Euromonitor International
Euromonitor International' s Cough, Cold and Allergy Products in Egypt report offers a comprehensive guide to the size and shape of the market at a national level. ...

Cough, Cold and Allergy (hay Fever) Remedies in Norway
Table of Contents Published: 2009/06 Published by: Euromonitor International
Euromonitor International' s Cough, Cold and Allergy Products in Norway report offers a comprehensive guide to the size and shape of the market at a national level. ...

Cough, Cold and Allergy (hay Fever) Remedies in Saudi Arabia
Table of Contents Published: 2009/06 Published by: Euromonitor International
Euromonitor International' s Cough, Cold and Allergy Products in Saudi Arabia report offers a comprehensive guide to the size and shape of the market at a national level. ...

Cough, Cold and Allergy (hay Fever) Remedies in Ukraine
Table of Contents Published: 2009/06 Published by: Euromonitor International
Euromonitor International' s Cough, Cold and Allergy Products in Ukraine report offers a comprehensive guide to the size and shape of the market at a national level. ...

Croatia Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
Of the 20 markets measured in BMIfs Q309 Pharmaceuticals & Healthcare Business Environment Rankings for Central and Eastern Europe (CEE), Croatia is placed 10th, reflecting the countryfs middleranking attractiveness for multinational companies. While ...

Cytotoxic Therapies Market Forecast
Table of Contents Published: 2009/06 Published by: Datamonitor
The cytotoxics market is mature and characterized by an increasing level of genericization. Several blockbuster products will undergo patent expiry during the forecast period, however, by virtue of these drugs' success, generic entry will ensure continued ...

Digestive Remedies in Argentina
Table of Contents Published: 2009/06 Published by: Euromonitor International
Euromonitor International' s Digestive Remedies in Argentina report offers a comprehensive guide to the size and shape of the market at a national level. ...

Digestive Remedies in Egypt
Table of Contents Published: 2009/06 Published by: Euromonitor International
Euromonitor International' s Digestive Remedies in Egypt report offers a comprehensive guide to the size and shape of the market at a national level. ...

Digestive Remedies in Norway
Table of Contents Published: 2009/06 Published by: Euromonitor International
Euromonitor International' s Digestive Remedies in Norway report offers a comprehensive guide to the size and shape of the market at a national level. ...

Digestive Remedies in Saudi Arabia
Table of Contents Published: 2009/06 Published by: Euromonitor International
Euromonitor International' s Digestive Remedies in Saudi Arabia report offers a comprehensive guide to the size and shape of the market at a national level. ...

Digestive Remedies in Ukraine
Table of Contents Published: 2009/06 Published by: Euromonitor International
Euromonitor International' s Digestive Remedies in Ukraine report offers a comprehensive guide to the size and shape of the market at a national level. ...

Drug Delivery Technologies: Controlled-release Players, products & prospects to 2018
Table of Contents Published: 2009/06 Published by: Espicom Business Intelligence
The controlled-release market was worth nearly US$21 billion globally in 2008. The sector is dominated by the launch of oral controlled-release formulations in key therapeutic areas such as the central nervous system, cardiovascular, metabolic and respira ...

Drug Delivery Technologies: Nano-enabled Delivery Players, products & prospects to 2018
Table of Contents Published: 2009/06 Published by: Espicom Business Intelligence
The true value of nanotechnology lies in its potential to improve the solubility and enhance the efficiency of product delivery. ...

Drug Delivery Technologies: Nucleic Acid Delivery Players, products & prospects to 2018
Table of Contents Published: 2009/06 Published by: Espicom Business Intelligence
The nucleic acid delivery market is maturing with over 1,450 clinical trials underway worldwide. The majority of these are in early clinical development (approximately 60%) with just over 3% in Phase III trials. Our analysis indicates that up to 35 novel ...

Drug Delivery Technologies: Players, products & prospects to 2018
Table of Contents Published: 2009/06 Published by: Espicom Business Intelligence
The time when advanced drug delivery was merely a means for profitable product life extension has gone. Drug delivery is now a major component of the pharmaceutical industry' s future and critical to bringing novel therapies to market. Indeed, without ...

Drug Delivery Technologies: Targeted Delivery Players, products & prospects to 2018
Table of Contents Published: 2009/06 Published by: Espicom Business Intelligence
Despite considerable advances in drug delivery technologies, there continues to be a high unmet clinical need for safer and better-tolerated drugs. Sub-optimal compliance and failure to persist with drug treatments are important determinants of therapeuti ...

Emerging Clinical Trial Locations - China: Market dynamics and the changing healthcare and regulatory environment
Table of Contents Published: 2009/06 Published by: Business Insights
Over the last decade pharmaceutical and biotechnology companies have entered a period where they have become confronted by a variety of complex issues affecting their operational efficiency and profitability. ...

Emerging Clinical Trial Locations - Eastern Europe: Market dynamics and the changing healthcare and regulatory environment
Table of Contents Published: 2009/06 Published by: Business Insights
Over the last decade pharmaceutical and biotechnology companies have entered a period where they have become confronted by a variety of complex issues affecting their operational efficiency and profitability. ...

Emerging Clinical Trial Locations - India: Market dynamics and the changing healthcare and regulatory environment
Table of Contents Published: 2009/06 Published by: Business Insights
Over the last decade pharmaceutical and biotechnology companies have entered a period where they have become confronted by a variety of complex issues affecting their operational efficiency and profitability. ...

Emerging Clinical Trial Locations -Latin America: Market dynamics and the changing healthcare and regulatory environment
Table of Contents Published: 2009/06 Published by: Business Insights
Over the last decade pharmaceutical and biotechnology companies have entered a period where they have become confronted by a variety of complex issues affecting their operational efficiency and profitability. It has now become generally acknowledged that ...

Emerging Clinical Trial Locations: Market dynamics and the changing healthcare and regulatory environment
Table of Contents Published: 2009/06 Published by: Business Insights
Over the last decade pharmaceutical and biotechnology companies have entered a period where they have become confronted by a variety of complex issues affecting their operational efficiency and profitability. ...

Emerging Markets Series: The Pharmaceutical Market of Poland
Table of Contents Published: 2009/06 Published by: Datamonitor
Poland' s economy has grown from strength to strength in the past 5 years, and despite the global economic downturn Poland is expected to maintain positive growth through 2010. However, concern exists over intellectual property and inconsistent drug reimb ...

Emerging Markets Series: The Pharmaceutical Market of Saudi Arabia
Table of Contents Published: 2009/06 Published by: Datamonitor
The Saudi Arabian pharmaceutical sector is becoming increasingly attractive for multinationals to enter driven by the expansion of private healthcare and altering patient demographics; and also for domestic generics companies as the government looks to ev ...

EMERGING MEDICAL TECHNOLOGIES REPORT
Table of Contents Published: 2009/06 Published by: Life Science Intelligence, Inc.
This 1000+ page report includes detailed 2-3 page executive summaries on 522 emerging medical device companies who have either presented at a Medtech Insight In3 investor/partnering conference or at an LSI (EMT) Emerging Medical Technologies Spotlight. ...

European HIV/AIDS and Hepatitis B/C Molecular Diagnostics Market
Table of Contents Published: 2009/06 Published by: Frost & Sullivan
This research service analyses the revenue potential for HIV/AIDS and Hepatitis B/C molecular diagnostics markets in major western European countries. It also gives the overview of the market in these regions together with market drivers,restraints and ch ...

Eye Care in Argentina
Table of Contents Published: 2009/06 Published by: Euromonitor International
Euromonitor International' s Eye Care in Argentina report offers a comprehensive guide to the size and shape of the market at a national level. ...

Eye Care in Egypt
Table of Contents Published: 2009/06 Published by: Euromonitor International
Euromonitor International' s Eye Care in Egypt report offers a comprehensive guide to the size and shape of the market at a national level. ...

Eye Care in Norway
Table of Contents Published: 2009/06 Published by: Euromonitor International
Euromonitor International' s Eye Care in Norway report offers a comprehensive guide to the size and shape of the market at a national level. ...

Eye Care in Saudi Arabia
Table of Contents Published: 2009/06 Published by: Euromonitor International
Euromonitor International' s Eye Care in Saudi Arabia report offers a comprehensive guide to the size and shape of the market at a national level. ...

Eye Care in Ukraine
Table of Contents Published: 2009/06 Published by: Euromonitor International
This report presents Eye Care in Ukraine. ...

Fibromyalgia Market Forecast
Table of Contents Published: 2009/06 Published by: Datamonitor
Until regulatory hurdles in the EU are overcome, the US offers the greatest commercial potential and will be the primary growth market for all current and future brands indicated for fibromyalgia. Datamonitor forecasts the fibromyalgia market to more than ...

Filling the Holes in the Drug Supply Chain (Strategic Focus)
Table of Contents Published: 2009/06 Published by: Datamonitor
The pharma industry is moving beyond the borders of US and Western Europe. As drug development costs reach astronomical levels, the burden to become lean falls on the manufacturers. To reduce costs, companies are moving their manufacturing facilities to o ...

Forecast Insight: Fibromyalgia - Regulatory caution threatens EU market expansion
Table of Contents Published: 2009/06 Published by: Datamonitor
Until regulatory hurdles in the EU are overcome, the US offers the greatest commercial potential and will be the primary growth market for all current and future brands indicated for fibromyalgia. Datamonitor forecasts the fibromyalgia market to more than ...

Forecast Insight: HIV - Cross-class fixed dose combinations drive continued growth
Table of Contents Published: 2009/06 Published by: Datamonitor
In 2008, antiretroviral sales across the seven major markets totaled $10.7 billion, growing at a CAGR of 12.8% between 2005 and 2008. Datamonitor expects this expansion to slow down. Despite drivers such as new product launches, earlier treatment initiati ...

Forecast Insight: Inflammatory Bowel Disease - New product launches sustain long-term market growth
Table of Contents Published: 2009/06 Published by: Datamonitor
The inflammatory bowel disease market is set to grow from $2.9 billion in 2008 to $4.5 billion in 2018 across the seven major markets. While Datamonitor' s updated forecast will parallel its previous forecast up to 2012, several new product launches, regi ...

Germany Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
Germanyfs drug market expenditure reached a value of EUR40.6bn (US$59.7bn) in 2008. The value of the countryfs pharmaceutical market is forecast to reach EUR48.6bn (US$61.6bn) by 2013, representing a compound annual growth rate (CAGR) of 3.69% in loca ...

Global Cardiovascular Drugs Market 2009-2024
Table of Contents Published: 2009/06 Published by: Visiongain
The years 2011 to 2015 will mark a period of high volatility in the cardiovascular market as key products - including blockbusters Plavix and Lovenox - face patent expiry. What types of therapeutic agent will enter the market from 2009 onwards, and what a ...

Global Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015
Table of Contents Published: 2009/06 Published by: Global Markets Direct
This report is an essential source for key information and data relating to global diabetes care devices market. The report provides global and country level, detailed and comprehensive coverage of market and category revenue, volume, distribution and com ...

Global Diabetes Market
Table of Contents Published: 2009/06 Published by: Frost & Sullivan
This research services details the market drivers, restraints, challenges, revenue forecasts of the insulin and the no-insulin market segments of the global diabetes market. It also deals with regional analysis of the US, Europe, Japan and rest of the wor ...

Global In Vitro Diagnostic Market Analysis
Table of Contents Published: 2009/06 Published by: RNCOS E-Services Pvt. Ltd.
The In vitro diagnostics (IVD) market represents one of the most lucrative segments in the global healthcare industry. Various factors, such as increasing prevalence of several chronic and infectious diseases, emerging technologies and increasing patient ...

Greece Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
Greecefs uncontrolled growth in drug expenditure, which increased by 59% between 2004 and 2008, has led the country to rank among the highest per capita spenders in Europe. While a proportion of this figure is likely attributable to the countryfs para ...

Healthcare Information Technology
Table of Contents Published: 2009/06 Published by: BCC Research
This report is an analytical business tool whose primary purpose is to describe and analyze the dynamics of the U.S. market for health care technology. It is particularly focused on clinical IT systems that facilitate or provide input into the care proces ...

Healthcare Technology Spending Through 2014 (Interactive Model)
Table of Contents Published: 2009/06 Published by: Datamonitor
As healthcare organizations increasingly turn to IT to decrease costs, improve the quality of care and increase access to care, it is important for technology vendors to understand where growth opportunities exist in the global healthcare market. ...

HIV Market Forecast
Table of Contents Published: 2009/06 Published by: Datamonitor
In 2008, antiretroviral sales across the seven major markets totaled $10.7 billion, growing at a CAGR of 12.8% between 2005 and 2008. Datamonitor expects this expansion to slow down. Despite drivers such as new product launches, earlier treatment initiati ...

Innovations in In-Vitro Diagnostics: New technologies, growth opportunities, and the future market outlook
Table of Contents Published: 2009/06 Published by: Business Insights
Clinical diagnostics is an attractive and growing industry, with the majority of major diagnostic companies experiencing sales growth of over 10% in2008, despite significant pricing pressures. ...


<< Previous Page:   4   5   6   7   8   9   10   11   12   13   14   15   Next >>

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.